Lates News

The China Development High-level Forum 2026 Annual Meeting opened grandly in Beijing. During the period, Novartis announced that it will continue to increase its investment in China to expand its research and development, production, and operational layout in China, with an expected investment of over 3.3 billion RMB to help promote innovation and high-quality development in the Chinese biopharmaceutical industry. (Jiemian)